Effect of Benazepril on Echocardiographic Indices in Dogs with Chronic Degenerative Valvular Diseases
World Small Animal Veterinary Association World Congress Proceedings, 2007
Shih Yang Wu; Hui Pi Huang
Department of Veterinary Medicine, National Taiwan University
Taipei, Taiwan


Benazepril, an angiotensin-converting enzyme inhibitor, is one of the most often used drugs in dogs with chronic degenerative valvular diseases (CDVD).


The aim of this study was to evaluate the effect of benazepril on the M-mode echocardiographic indices in dogs with CDVD (classification β / X).

Materials and Methods

Eight client-owned dogs presented with clinical signs related to CDVD were investigated. The diagnosis of heart failure was based on clinical signs, chest radiographs, electrocardiography, and echocardiography. The M-mode echocardiographic indices were measured before and two-month after benazepril administration. After benazepril administration (0.1 mg/Kg/day), clinical signs associated with heart failure, including cough, respiratory effort, appetite, and exercise endurance, were evaluated by both clients and veterinarians.


Significant differences of the before and after benazepril administered were noted in echocardiographic indices including end-systolic left ventricular diameter (p = 0.01) and ratio of left atrium to aorta (p = 0.01). No substantial changes of fractional shortening, ejection fraction, end-diastolic diameter, and E-point septal separation were found to be related to benazepril administered. Clinical improvement was clearly recognized in all dogs (p = 0.02).


The result of this investigation indicated that benazepril (0.1 mg/Kg per day) was able to improve end-systolic atrial and ventricular indices assessed using M-mode echocardiography in dogs with CDVD.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Shih-Yang Wu
National Taiwan University

MAIN : Abstracts - Poster : Benazepril & Echocardiographic Indices
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357